用年龄归一化HRV特征提升睡眠期无创血糖预测准确率
Age-Normalized HRV Features for Non-Invasive Glucose Prediction: A Pilot Sleep-Aware Machine Learning Study
- 将心率变异性数据按年龄因子归一化,消除生理老化干扰
- 归一化后对血糖对数预测的决定系数达0.161,提升25.6%
- 适合关注无创血糖监测与睡眠生理建模的研究者
无创血糖监测仍是糖尿病管理中的关键挑战。睡眠期间的心率变异性(HRV)在血糖预测中展现出潜力,但年龄相关的自主神经变化严重干扰传统HRV分析。本研究分析了43名受试者多模态数据,包括睡眠阶段特异的ECG、HRV特征及临床指标。采用新颖的年龄归一化方法,将原始HRV值除以年龄相关缩放因子。使用贝叶斯岭回归与5折交叉验证进行对数血糖预测。归一化后特征达到R² = 0.161(MAE = 0.182),相比未归一化特征(R² = 0.132)提升25.6%。最优预测特征为:hrv rem mean rr age normalized(r = 0.443, p = 0.004)、hrv ds mean rr age normalized(r = 0.438, p = 0.005)和舒张压(r = 0.437, p = 0.005)。系统性消融实验确认年龄归一化是核心贡献,且睡眠阶段特异性特征带来额外预测价值。年龄归一化后的HRV特征显著提升血糖预测准确性。该睡眠感知方法克服了自主神经评估的根本局限,初步验证了无创血糖监测的可行性。但结果仍需在更大队列中验证后方可考虑临床应用。
原文摘要 · Abstract (English)
Non-invasive glucose monitoring remains a critical challenge in the management of diabetes. HRV during sleep shows promise for glucose prediction however, age-related autonomic changes significantly confound traditional HRV analyses. We analyzed 43 subjects with multi-modal data including sleep-stage specific ECG, HRV features, and clinical measurements. A novel age-normalization technique was applied to the HRV features by, dividing the raw values by age-scaled factors. BayesianRidge regression with 5-fold cross-validation was employed for log-glucose prediction. Age-normalized HRV features achieved R2 = 0.161 (MAE = 0.182) for log-glucose prediction, representing a 25.6% improvement over non-normalized features (R2 = 0.132). The top predictive features were hrv rem mean rr age normalized (r = 0.443, p = 0.004), hrv ds mean rr age normalized (r = 0.438, p = 0.005), and diastolic blood pressure (r = 0.437, p = 0.005). Systematic ablation studies confirmed age-normalization as the critical component, with sleep-stage specific features providing additional predictive value. Age-normalized HRV features significantly enhance glucose prediction accuracy compared with traditional approaches. This sleep-aware methodology addresses fundamental limitations in autonomic function assessment and suggests a preliminary feasibility for non-invasive glucose monitoring applications. However, these results require validation in larger cohorts before clinical consideration.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。